TAIDOC TECHNOLOGY CORP (4736) - Total Assets
Based on the latest financial reports, TAIDOC TECHNOLOGY CORP (4736) holds total assets worth NT$13.07 Billion TWD (≈ $411.83 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
TAIDOC TECHNOLOGY CORP - Total Assets Trend (2009–2025)
This chart illustrates how TAIDOC TECHNOLOGY CORP's total assets have evolved over time, based on quarterly financial data. Also see TAIDOC TECHNOLOGY CORP (4736) total market value for the company's overall valuation and market capitalisation.
TAIDOC TECHNOLOGY CORP - Asset Composition Analysis
Current Asset Composition (September 2025)
TAIDOC TECHNOLOGY CORP's total assets of NT$13.07 Billion consist of 59.2% current assets and 40.8% non-current assets. Review 4736 total debt and obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 16.2% |
| Accounts Receivable | NT$996.07 Million | 7.8% |
| Inventory | NT$1.27 Billion | 9.9% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$5.09 Million | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2009–2025)
This chart illustrates how TAIDOC TECHNOLOGY CORP's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 4736 share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: TAIDOC TECHNOLOGY CORP's current assets represent 59.2% of total assets in 2025, an increase from 52.2% in 2009.
- Cash Position: Cash and equivalents constituted 16.2% of total assets in 2025, down from 21.6% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2009.
- Asset Diversification: The largest asset category is inventory at 9.9% of total assets.
TAIDOC TECHNOLOGY CORP Competitors by Total Assets
Key competitors of TAIDOC TECHNOLOGY CORP based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Rua Life Sciences PLC
LSE:RUA
|
UK | GBX9.12 Million |
|
Semler Scientific Inc
NASDAQ:SMLR
|
USA | $596.68 Million |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
|
China | CN¥1.46 Billion |
|
Ningbo David Medical Device Co Ltd
SHE:300314
|
China | CN¥1.45 Billion |
|
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562
|
China | CN¥1.42 Billion |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607
|
China | CN¥988.48 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Peijia Medical Limited
F:4WO
|
Germany | €2.66 Billion |
TAIDOC TECHNOLOGY CORP - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.73 | 2.22 | 3.57 |
| Quick Ratio | 2.28 | 1.82 | 2.62 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$4.91 Billion | NT$3.87 Billion | NT$4.00 Billion |
TAIDOC TECHNOLOGY CORP - Advanced Valuation Insights
This section examines the relationship between TAIDOC TECHNOLOGY CORP's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.22 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 4.5% |
| Total Assets | NT$12.78 Billion |
| Market Capitalization | $385.16 Million USD |
Valuation Analysis
Below Book Valuation: The market values TAIDOC TECHNOLOGY CORP's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: TAIDOC TECHNOLOGY CORP's assets grew by 4.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for TAIDOC TECHNOLOGY CORP (2009–2025)
The table below shows the annual total assets of TAIDOC TECHNOLOGY CORP from 2009 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | NT$12.78 Billion ≈ $402.78 Million |
+4.45% |
| 2024-09-30 | NT$12.24 Billion ≈ $385.62 Million |
+2.81% |
| 2023-09-30 | NT$11.91 Billion ≈ $375.08 Million |
-7.73% |
| 2022-09-30 | NT$12.90 Billion ≈ $406.49 Million |
+22.62% |
| 2021-09-30 | NT$10.52 Billion ≈ $331.52 Million |
+14.76% |
| 2020-09-30 | NT$9.17 Billion ≈ $288.87 Million |
+17.14% |
| 2019-09-30 | NT$7.83 Billion ≈ $246.61 Million |
+3.89% |
| 2018-09-30 | NT$7.53 Billion ≈ $237.37 Million |
+24.23% |
| 2017-09-30 | NT$6.06 Billion ≈ $191.07 Million |
+19.68% |
| 2016-09-30 | NT$5.07 Billion ≈ $159.65 Million |
+16.82% |
| 2015-09-30 | NT$4.34 Billion ≈ $136.66 Million |
+9.57% |
| 2014-09-30 | NT$3.96 Billion ≈ $124.72 Million |
+24.07% |
| 2013-09-30 | NT$3.19 Billion ≈ $100.52 Million |
+3.94% |
| 2012-09-30 | NT$3.07 Billion ≈ $96.71 Million |
+1.29% |
| 2011-09-30 | NT$3.03 Billion ≈ $95.48 Million |
-1.37% |
| 2010-09-30 | NT$3.07 Billion ≈ $96.81 Million |
+15.47% |
| 2009-09-30 | NT$2.66 Billion ≈ $83.84 Million |
-- |
About TAIDOC TECHNOLOGY CORP
TaiDoc Technology Corporation manufactures and markets medical devices in Taiwan and internationally. The company offers In vitro diagnostics products, including multiple parameter monitoring systems, point of care testing devices, and lancet and lancing devices; vet health care products comprise blood glucose and calcium meters, and blood ketone meters; and medical devices, such as nebulizers, t… Read more